Author

abdala bulbo With three doses Cuba's Covid-19 vaccine candidate, Abdala, showed 92,28 percent efficacy in Phase III trial, its developers reported on Monday.

turismo1

The winter high season in the Holguín tourist pole will maintain similar air operations to the territory as in the last one, with around 68 weekly operations from seven markets, including the incorporation of two new direct connections from Prague, Czech Republic, which began on November 2 and soon, the destination will be connected to the capital of Slovakia, Bratislava.

A recent study developed in the Cuban province of Matanzas (western Cuba) proved the efficacy of immunotherapy to fight non-small cell lung cancer (NSCLC) in advanced stages, based on national biotechnological products.

The main projections of Special Education for the current school year in the province of Holguin are focused on vocational training, professional and teacher orientation, methodological, preventive, political and ideological work, as well as the improvement of the national education system. Read more Projections of Special Education in Holguin

f0205393 Photo: Taken from Granma

More than four million doses of the Covid-19 Abdala (CIGB-66) vaccine, the first such immunizer conceived and produced in Latin America, have been so far administrated to children and adolescents in Cuba and Nicaragua.

Page 358 of 498

Cuba confirms 92.28% efficacy of Abdala vaccine

Holguín: Good forecast for high international tourism season

Cuban study shows efficacy of Cuban immunotherapy against lung cancer

Projections of Special Education in Holguin

Over four million Cuban children vaccinated with Abdala vaccine

More Articles